Stay updated on DS8201a and Pembrolizumab in Advanced Cancer Clinical Trial
Sign up to get notified when there's something new on the DS8201a and Pembrolizumab in Advanced Cancer Clinical Trial page.

Latest updates to the DS8201a and Pembrolizumab in Advanced Cancer Clinical Trial page
- Check4 days agoChange DetectedA new note indicating NIH funding in 2018 was added to the study's identifiers. This adds funding context to the trial but does not change its design, population, or outcomes.SummaryDifference0.0%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe page's revision label was updated from v3.6.4 to v3.6.5, indicating a maintenance update to the site's code or templates rather than a change to study information.SummaryDifference0.0%

- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe page revision was updated from v3.6.3 to v3.6.4, signaling a maintenance release to the ClinicalTrials.gov entry. The study details appear unchanged in this update.SummaryDifference0.0%

- Check61 days agoChange DetectedThe revision tag has changed from v3.6.0 to v3.6.3, indicating a version bump for the page or its underlying components. This update appears to be an internal version increment rather than a visible content change.SummaryDifference0.0%

- Check75 days agoChange DetectedAdds an explicit recruitment notice 'No longer looking for participants' and new help/navigation items (How to Read a Study Record, Common Questions, How to Join a Study). The revision tag updates from v3.5.5 to v3.6.0.SummaryDifference0.3%

- Check82 days agoChange DetectedThe page's revision label was updated from v3.5.4 to v3.5.5, indicating a new revision entry for this page.SummaryDifference0.0%

Stay in the know with updates to DS8201a and Pembrolizumab in Advanced Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the DS8201a and Pembrolizumab in Advanced Cancer Clinical Trial page.